Loading...
According to a recent letter from Pfizer, nelfinavir now meets the FDA’s final limits for ethyl methanesulfonate (EMS) and can once again be prescribed to children and pregnant women as appropriate. Nefinavir has not been recommended for use in these populations since last fall, when the drug was found to contain low levels of EMS, a potential carcinogen (ACC Sep 24 2007).